2 transcripts
ALKS
Earnings call transcript
NASDAQ
2024 Q1
1 May 24
is that we have a number of nonrecurring expenses in the first quarter that apply to the R&D group that imply payroll taxes and things like share-based comp
ALKS
Earnings call transcript
NASDAQ
2023 Q4
15 Feb 24
patent matter, and most notably, the separation of the oncology business, which had operational, financial and tax consequences.
As a result
- Prev
- 1
- Next